127 related articles for article (PubMed ID: 2673775)
21. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
McMahan J; Linneman T
Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
[TBL] [Abstract][Full Text] [Related]
22. Immobilization hypercalcemia associated with Landry-Guillain-Barré syndrome. Successful therapy with combined calcitonin and etidronate.
Meythaler JM; Korkor AB; Nanda T; Kumar NA; Fallon M
Arch Intern Med; 1986 Aug; 146(8):1567-71. PubMed ID: 3089187
[TBL] [Abstract][Full Text] [Related]
23. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
Arthritis Rheum; 2001 Jul; 44(7):1496-503. PubMed ID: 11465699
[TBL] [Abstract][Full Text] [Related]
24. Hypercalcemia: an evidence-based approach to clinical cases.
Assadi F
Iran J Kidney Dis; 2009 Apr; 3(2):71-9. PubMed ID: 19395781
[TBL] [Abstract][Full Text] [Related]
25. A case of temporary severe disequilibrium hypercalcemia.
Kogawa K; Inaba M; Okuno Y; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1994; 20(3):163-8. PubMed ID: 7816007
[TBL] [Abstract][Full Text] [Related]
26. Maxilla osseus sequestre and oral exposure: effects of the treatment of multiple myeloma with bisphosphonates.
Lobato JV; Rodrigues JM; Cavaleiro MV; Lobato JM; Xavier L; Santos JD; Maurício AC
Acta Med Port; 2007; 20(2):185-92. PubMed ID: 17868526
[TBL] [Abstract][Full Text] [Related]
27. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
Bikle DD
Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
[TBL] [Abstract][Full Text] [Related]
28. Bone resorption and renal calcium reabsorption in renal cell carcinoma-bearing mice: the effects of bisphosphonate.
Weissglas M; Löwik C; Schamhart D; Theuns H; Kurth KH; Papapoulos S
BJU Int; 2007 Jun; 99(6):1530-3. PubMed ID: 17428243
[TBL] [Abstract][Full Text] [Related]
29. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
Falk S; Kratzsch J; Paschke R; Koch CA
Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
[TBL] [Abstract][Full Text] [Related]
30. Hypercalcemia and bone resorption in malignancy.
Walls J; Bundred N; Howell A
Clin Orthop Relat Res; 1995 Mar; (312):51-63. PubMed ID: 7634618
[TBL] [Abstract][Full Text] [Related]
31. A retrospective evaluation of the medical treatment of malignancy-associated hypercalcemia.
Kimura S; Sato Y; Matsubara H; Adachi I; Yamaguchi K; Suzuki M; Suemasu K; Abe K
Jpn J Cancer Res; 1986 Jan; 77(1):85-91. PubMed ID: 2937761
[TBL] [Abstract][Full Text] [Related]
32. [Severe Vitamin D(dihydrotachysterol)-intoxication with temporary anemia and hypercalcemia responsive to bisphosphonates].
Blind E; Fassnacht M; Körber C; Körber-Hafner N; Reiners C; Allolio B
Dtsch Med Wochenschr; 2001; 126(12):T21-T24. PubMed ID: 12751020
[TBL] [Abstract][Full Text] [Related]
33. Immobilization hypercalcemia in spinal cord injury.
Maynard FM; Imai K
Arch Phys Med Rehabil; 1977 Jan; 58(1):16-24. PubMed ID: 831659
[TBL] [Abstract][Full Text] [Related]
34. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
Rosner MH; Dalkin AC
Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
[TBL] [Abstract][Full Text] [Related]
35. Overview of cancer-related hypercalcemia: epidemiology and etiology.
Muggia FM
Semin Oncol; 1990 Apr; 17(2 Suppl 5):3-9. PubMed ID: 2185551
[TBL] [Abstract][Full Text] [Related]
36. Treatment of cancer-related hypercalcemia.
Ritch PS
Semin Oncol; 1990 Apr; 17(2 Suppl 5):26-33. PubMed ID: 2185550
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of hypercalcemia].
Godeau P; Wechsler B; Lambrozo J
Sem Hop; 1977 Jun; 53(24):1405-9. PubMed ID: 197628
[TBL] [Abstract][Full Text] [Related]
38. Hypercalcemia in cancer patients: pathobiology and management.
Santarpia L; Koch CA; Sarlis NJ
Horm Metab Res; 2010 Mar; 42(3):153-64. PubMed ID: 19960404
[TBL] [Abstract][Full Text] [Related]
39. Mechanism of the hypocalcemic effect of mithramycin.
Kiang DT; Loken MK; Kennedy BJ
J Clin Endocrinol Metab; 1979 Feb; 48(2):341-4. PubMed ID: 155075
[TBL] [Abstract][Full Text] [Related]
40. Hypercalcemia and hyperosteolysis in vitamin D intoxication: effects of clodronate therapy.
Rizzoli R; Stoermann C; Ammann P; Bonjour JP
Bone; 1994; 15(2):193-8. PubMed ID: 8086237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
